- Home
- INMD vs OPK Comparison
INMD vs OPK Comparison
Compare INMD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- OPK
- Stock Information
- Founded
- INMD 2008
- OPK 2007
- Country
- INMD Israel
- OPK United States
- Employees
- INMD N/A
- OPK N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- INMD Health Care
- OPK Health Care
- Exchange
- INMD Nasdaq
- OPK Nasdaq
- Market Cap
- INMD 957.6M
- OPK 1.1B
- IPO Year
- INMD 2019
- OPK 1995
- Fundamental
- Price
- INMD $15.04
- OPK $1.55
- Analyst Decision
- INMD Hold
- OPK Buy
- Analyst Count
- INMD 6
- OPK 3
- Target Price
- INMD $16.81
- OPK $2.63
- AVG Volume (30 Days)
- INMD 740.8K
- OPK 2.5M
- Earning Date
- INMD 10-29-2025
- OPK 11-06-2025
- Dividend Yield
- INMD N/A
- OPK N/A
- EPS Growth
- INMD 46.63
- OPK N/A
- EPS
- INMD 2.54
- OPK N/A
- Revenue
- INMD $401,561,000.00
- OPK $664,029,000.00
- Revenue This Year
- INMD N/A
- OPK N/A
- Revenue Next Year
- INMD $5.30
- OPK $0.84
- P/E Ratio
- INMD $5.94
- OPK N/A
- Revenue Growth
- INMD N/A
- OPK N/A
- 52 Week Low
- INMD $13.14
- OPK $1.11
- 52 Week High
- INMD $19.85
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- INMD 52.23
- OPK 61.26
- Support Level
- INMD $14.88
- OPK $1.51
- Resistance Level
- INMD $15.60
- OPK $1.60
- Average True Range (ATR)
- INMD 0.39
- OPK 0.07
- MACD
- INMD 0.00
- OPK 0.01
- Stochastic Oscillator
- INMD 43.08
- OPK 75.00
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.